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Retrospective testing of 3,232 serum samples from the 
general population and 518 serum samples from a high-risk 
group showed no evidence of human exposure to Neospora 
caninum in England. Results were obtained by using im-
munoﬂ  uorescence antibody testing and ELISA to analyze 
frequency distribution. 
T
he protozoan parasite Neospora caninum has recently 
emerged as a major cause of disease in cattle and dogs 
worldwide (1). An issue of concern is that N. caninum might 
be zoonotic because of its close biologic relationship to the 
common zoonotic parasite Toxoplasma gondii and because 
rhesus monkeys have been experimentally infected (2). Hu-
mans could become exposed to N. caninum by accidental 
ingestion of oocysts shed in the feces of canid deﬁ  nitive 
hosts or following the consumption of raw or inadequately 
cooked meat that contains tissue cysts. This retrospective 
study sought immunologic evidence of human exposure to 
N. caninum in England. Two cohorts of the population were 
examined: a convenience collection, which approximated 
the general population, and a putative high-risk group.
The Study
The ﬁ  rst cohort comprised anonymized residues of se-
rum samples submitted in 2000 for microbiologic or bio-
chemical testing for diagnostic or screening purposes to 11 
laboratories in England that were contributing to the Public 
Health Laboratories Service (PHLS) Serologic Surveil-
lance Programme (now Health Protection Agency [HPA]) 
Seroepidemiology Programme (3). The second cohort 
comprised 518 samples collected in 1995 from the PHLS 
cohort of farm workers, which was recruited in 1991 to 
provide annual samples from a population at high risk for 
zoonotic infections from livestock (4,5). Ethical approval 
was granted by relevant ethics committees.
Serum specimens were initially screened at a dilution 
of 1:10 in phosphate-buffered saline (PBS), pH 7.2, con-
taining Tween 20 (PBS/Tween) with an inhibition ELISA 
developed in our laboratory and previously validated in 
cattle and dogs (6). Positive and negative bovine serum 
controls were used on each ELISA plate. In the absence of 
a human positive control, we used a primate serum sample 
as a further positive control. Optical density was read at 
450 nm, and percentage inhibition (PI) values were calcu-
lated by using the formula 100 – [(test OD/negative con-
trol OD) ×100]. Without speciﬁ  c validation, a cut-off of 
20% inhibition was chosen to indicate putative positives. 
This cut-off has been used for previous comparison of the 
inhibition ELISA with a conventional N. caninum–specif-
ic ELISA in bovine sera (6). All samples with inhibition 
>20% were subsequently tested in an immunoﬂ  uorescence 
antibody test (IFAT) (7) with appropriate species-speciﬁ  c 
ﬂ   uorescein isothiocynate conjugates. All samples were 
tested at a dilution of 1:50 with positive controls of bovine 
and primate N. caninum serum and bovine negative control 
serum as above. For the inhibition ELISA results, the dis-
tribution of the data was examined ﬁ  rst by plotting percent 
inhibition, with the data aggregated into bands of 10%. The 
plots were repeated after logging the data and putting it into 
bins (equal width reactivity categories based on log 10% 
[log10] inhibition). The distribution of log10 inhibition was 
also examined according to person’s sex and age and the 
submitting laboratory.
From the HPA collection, 3,232 samples from persons 
20–70 years of age were tested; 1,889 (58.45%) were from 
women. The PHLS farm cohort, comprised 74% men and 
26% women, with a median age range of 41–50 years (5). 
Six hundred and ninety-one (21.38%) of the HPA samples 
and 29 (5.56%) of the PHLS samples produced percentage 
inhibition of >20% in the inhibition ELISA test (Table). 
For the bovine-positive controls, mean percentage inhi-
bition was 79.76% (5% conﬁ  dence interval [CI] 78.94–
80.58, n = 200). The primate-positive serum had a PI of 
63.00% (average of 2 tests). When samples with a PI >20% 
in the inhibition ELISA were tested by IFAT, all failed to 
give positive ﬂ  uorescence results, whereas the primate- 
and bovine-positive controls consistently gave positive 
ﬂ  uorescence results.
The frequency distribution of actual percentage inhi-
bitions for the HPA samples showed a single positively 
skewed distribution. After the data were logged, the plot 
showed a single log-normal distribution, with a mean close 
to 0% inhibition, i.e., similar to the negative control used. 
There was no evidence that the percentage inhibition dif-
fered by sex or region (results not shown) or by age (Fig-
ure). The log-transformed inhibition data for the PHLS co-
hort also produced a single normal frequency distribution 
about a mean close to 0% inhibition (Figure).
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In this study, we sought evidence of human exposure 
to N. caninum infection by speciﬁ  c antibody detection in 
2 populations. Since no serologic assay has been validated 
for N. caninum antibodies in humans, we used an inhibi-
tion ELISA and analyzed the frequency distribution of the 
percentage inhibitions. Although initial screening gave 
several putative positives, when the frequency distribu-
tion curves were plotted, no evidence was found show-
ing that the samples were distributed discretely into those 
with antibody to Neospora spp. and those without. This 
provides strong evidence that no Neospora-speciﬁ  c im-
munoglobulin G was found in any of the samples and that 
the distribution observed describes a single population of 
nonexposed persons. Moreover, no change in distribution 
was observed with age, further evidence that the dataset 
is from a single large population for which results were 
negative. Finally, conﬁ  rmatory testing with the IFAT of 
all samples with >20% inhibition in the inhibition ELI-
SA, failed to detect any speciﬁ  c ﬂ  uorescence indicative 
of true positives. The fact that the predictive value of a 
negative test is very high in low prevalence populations, 
even with tests of modest performance, further supports 
the conclusion that infection with N. caninum is unlikely. 
We therefore conclude that these sera show no evidence 
of exposure to N. caninum.
Selection bias in the HPA sera collection is unlikely 
because of the provision of free access to healthcare for all 
by the National Health Service. Moreover, a convenience 
collection has been shown to be comparable to a random-
ized sample in previous studies of population immunity (8). 
The collection may therefore be considered to approximate 
the general population of England in terms of its exposure 
to N. caninum. In contrast, the PHLS farm cohort may be 
regarded as a relatively high-risk group for N. caninum 
infection since those persons would be predicted to have 
greater than normal exposure to bovine placentas, fetal 
membranes, and ﬂ  uids that are potentially infected, or to 
environments contaminated by feces of dogs, which have 
access to tissues from potentially infected cattle.
Analyses to detect parasites or parasite DNA have 
shown no deﬁ  nitive evidence of human infection with N. 
caninum (1), but seropositivity has been reported in 3 stud-
ies (9–11) although not in 2 other European surveys (12,13). 
Of the 3 reports describing seropositivity, 2 (10,11) noted 
a high correlation with seropositivity to T. gondii, and, in 
all, antibody titers versus N. caninum antigen were low (at 
<1:100 dilution). The interpretation of serologic results is 
difﬁ  cult, and this study’s approach, in which large numbers 
of samples were quantitatively assayed to give a frequency 
distribution, may provide a helpful means of addressing 
this uncertainty.
Conclusions
No evidence of human exposure to N. caninum was 
found in a high-risk population in England sampled in 1995 
and in a sample of the general population of England col-
lected in 2000. These results suggest that human infection 
is unlikely in England. However, given global variation in 
infection prevalence in cattle and possible regional differ-
ences in the incidence of oocyst shedding by dogs, there 
remains a need worldwide to remain vigilant to the pos-
sibility of human infection.
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Table. Results of inhibition ELISA for Neospora caninum, England* 
% inhibition
Population <20 >20–<30 >30–<40 >40–<50 >50
No. samples 
tested
HPA seroepidemiology study 2,541 350 201 98 42 3,232
PHLS farm workers cohort 499 12 14 3 0 518
*HPA, Health Protection Agency; PHLS, Public Health Laboratory Service. 
Figure. Frequency distribution of inhibition ELISA results for 
Neospora caninum, England (Health Protection Agency serum 
samples), stratiﬁ  ed by age group. *Equal-width bands based on 
log10 percentage inhibition.References
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etymologia etymologia
Bartonella henselae 
[bär′′ tə-nel′ə henz′ ə-lā]
Bartonella is a genus of gram-negative bacteria named after Peruvian scientist Alberto 
Leonardo Barton. He identiﬁ  ed a unique bacterium in 1905 during an outbreak among workers 
building a railway between Lima and La Oroya, a mining town in the Andes. The illness, 
usually fatal, was characterized by fever and severe anemia. Many of the sick were brought to 
Guadalupe Hospital in Lima, where Dr. Barton isolated the etiologic agent (which had been 
transmitted by sandﬂ  ies) in patients’ blood cells. It was later called Bartonella bacilliformis.
The species B. henselae was named after Diane Hensel, a technologist in the clinical 
microbiology laboratory, University Hospitals, Oklahoma City, who in 1985 observed a 
Campylobacter-like organism in blood cultures of HIV-infected patients. The organism was 
ﬁ  rst named Rochalimaea henselae and then B. henselae, when sequencing showed identity with 
that genus.
Sources: Dorland’s illustrated medical dictionary, 31st edition. Philadelphia: Saunders; 2007; http://www.whonamedit.com; 
Barton AL. Descripción de elementos endo-globulares hallados en las enfermos de ﬁ  ebre verrucosa. La Crónica médica de Lima. 
1909;26:7–10; http://sisbib.unmsm.edu.pe/BVrevistas/folia/Vol8_N4_dic97/bartonella.htm